These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20491477)

  • 1. Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia.
    Pinard E; Alanine A; Alberati D; Bender M; Borroni E; Bourdeaux P; Brom V; Burner S; Fischer H; Hainzl D; Halm R; Hauser N; Jolidon S; Lengyel J; Marty HP; Meyer T; Moreau JL; Mory R; Narquizian R; Nettekoven M; Norcross RD; Puellmann B; Schmid P; Schmitt S; Stalder H; Wermuth R; Wettstein JG; Zimmerli D
    J Med Chem; 2010 Jun; 53(12):4603-14. PubMed ID: 20491477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors.
    Pinard E; Alberati D; Bender M; Borroni E; Brom V; Burner S; Fischer H; Hainzl D; Halm R; Hauser N; Jolidon S; Lengyel J; Marty HP; Meyer T; Moreau JL; Mory R; Narquizian R; Norcross RD; Schmid P; Wermuth R; Zimmerli D
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6960-5. PubMed ID: 20974532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia.
    Alberati D; Moreau JL; Lengyel J; Hauser N; Mory R; Borroni E; Pinard E; Knoflach F; Schlotterbeck G; Hainzl D; Wettstein JG
    Neuropharmacology; 2012 Feb; 62(2):1152-61. PubMed ID: 22138164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey.
    Eddins D; Hamill TG; Puri V; Cannon CE; Vivian JA; Sanabria-Bohórquez SM; Cook JJ; Morrow JA; Thomson F; Uslaner JM
    Psychopharmacology (Berl); 2014 Feb; 231(3):511-9. PubMed ID: 24051602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACS chemical neuroscience molecule spotlight on RG1678.
    Hopkins CR
    ACS Chem Neurosci; 2011 Dec; 2(12):685-6. PubMed ID: 22860161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Biological Evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1.
    Cioffi CL; Liu S; Wolf MA; Guzzo PR; Sadalapure K; Parthasarathy V; Loong DT; Maeng JH; Carulli E; Fang X; Karunakaran K; Matta L; Choo SH; Panduga S; Buckle RN; Davis RN; Sakwa SA; Gupta P; Sargent BJ; Moore NA; Luche MM; Carr GJ; Khmelnitsky YL; Ismail J; Chung M; Bai M; Leong WY; Sachdev N; Swaminathan S; Mhyre AJ
    J Med Chem; 2016 Sep; 59(18):8473-94. PubMed ID: 27559615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zwitterionic CRTh2 antagonists.
    Luker T; Bonnert R; Paine SW; Schmidt J; Sargent C; Cook AR; Cook A; Gardiner P; Hill S; Weyman-Jones C; Patel A; Thom S; Thorne P
    J Med Chem; 2011 Mar; 54(6):1779-88. PubMed ID: 21355602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient.
    Pinard E; Borroni E; Koerner A; Umbricht D; Alberati D
    Chimia (Aarau); 2018 Aug; 72(7):477-484. PubMed ID: 30158010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.
    Procopiou PA; Ancliff RA; Bamford MJ; Browning C; Connor H; Davies S; Fogden YC; Hodgson ST; Holmes DS; Looker BE; Morriss KM; Parr CA; Pickup EA; Sehmi SS; White GV; Watts CJ; Wilson DM; Woodrow MD
    J Med Chem; 2007 Dec; 50(26):6706-17. PubMed ID: 18052318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
    Harada K; Nakato K; Yarimizu J; Yamazaki M; Morita M; Takahashi S; Aota M; Saita K; Doihara H; Sato Y; Yamaji T; Ni K; Matsuoka N
    Eur J Pharmacol; 2012 Jun; 685(1-3):59-69. PubMed ID: 22542656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) Inhibitors.
    Amberg W; Lange UEW; Ochse M; Pohlki F; Behl B; Relo AL; Hornberger W; Hoft C; Mezler M; Sydor J; Wang Y; Zhao H; Brewer JT; Dietrich J; Li H; Akritopoulou-Zanze I; Lao Y; Hannick SM; Ku YY; Vasudevan A
    J Med Chem; 2018 Sep; 61(17):7503-7524. PubMed ID: 30080045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
    Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas.
    Perry KW; Falcone JF; Fell MJ; Ryder JW; Yu H; Love PL; Katner J; Gordon KD; Wade MR; Man T; Nomikos GG; Phebus LA; Cauvin AJ; Johnson KW; Jones CK; Hoffmann BJ; Sandusky GE; Walter MW; Porter WJ; Yang L; Merchant KM; Shannon HE; Svensson KA
    Neuropharmacology; 2008 Oct; 55(5):743-54. PubMed ID: 18602930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies.
    Zeng Z; O'Brien JA; Lemaire W; O'Malley SS; Miller PJ; Zhao Z; Wallace MA; Raab C; Lindsley CW; Sur C; Williams DL
    Nucl Med Biol; 2008 Apr; 35(3):315-25. PubMed ID: 18355687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine transport inhibitors in the treatment of schizophrenia.
    Javitt DC
    Handb Exp Pharmacol; 2012; (213):367-99. PubMed ID: 23027421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of N-(2-(azepan-1-yl)-2-phenylethyl)-benzenesulfonamides as novel inhibitors of GlyT1.
    Varnes JG; Forst JM; Hoerter TN; Holmquist CR; Wilkins DE; Tian G; Jonak G; Wang X; Potts WM; Wood MW; Alhambra C; Brugel TA; Albert JS
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4878-81. PubMed ID: 20637614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors.
    Pinard E; Alberati D; Borroni E; Fischer H; Hainzl D; Jolidon S; Moreau JL; Narquizian R; Nettekoven M; Norcross RD; Stalder H; Thomas AW
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5134-9. PubMed ID: 18752953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel, non-substrate-based series of glycine type 1 transporter inhibitors derived from high-throughput screening.
    Lowe J; Drozda S; Qian W; Peakman MC; Liu J; Gibbs J; Harms J; Schmidt C; Fisher K; Strick C; Schmidt A; Vanase M; Lebel L
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1675-8. PubMed ID: 17257843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors.
    Smith G; Ruhland T; Mikkelsen G; Andersen K; Christoffersen CT; Alifrangis LH; Mørk A; Wren SP; Harris N; Wyman BM; Brandt G
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4027-30. PubMed ID: 15225720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.